As described earlier, this methodology is grounded in previously published literature and uses publicly available information (for example, the OPAIS database) as well as claims-level data to determine the total number of units of a Part D rebatable drug for which a discount was provided under the 340B Program for the last 3 calendar quarters of the applicable period that begins on October 1, 2025 to implement section 1860D-14B(b)(1)(B) of the Act
PlexusDx serves all 50 states without requiring insurance coverage, membership fees, or prior authorization delays
We believe that cross-walking NPI to MPN is a necessary step in utilizing publicly available information to establish a list of 340B providers, which is an essential element to provide a transparent Prescriber-Pharmacy Methodology
By following the outlined guidelinesranging from safe storage and mixing techniques to proper injection methods and monitoring for side effectsyou can ensure a positive experience with your therapy
Arch Immunol Ther Exp (Warsz) 2023, 71 (1), 16
Effect of kiwifruit consumption on sleep quality in adults with sleep problems
